XTNT Relative Valuation
XTNT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, XTNT is overvalued; if below, it's undervalued.
Historical Valuation
Xtant Medical Holdings Inc (XTNT) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -12.26. The fair price of Xtant Medical Holdings Inc (XTNT) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：0.61
Fair
-122.06
PE
1Y
3Y
5Y
Trailing
Forward
10.37
EV/EBITDA
Xtant Medical Holdings Inc. (XTNT) has a current EV/EBITDA of 10.37. The 5-year average EV/EBITDA is 21.36. The thresholds are as follows: Strongly Undervalued below -19.28, Undervalued between -19.28 and 1.04, Fairly Valued between 41.68 and 1.04, Overvalued between 41.68 and 62.00, and Strongly Overvalued above 62.00. The current Forward EV/EBITDA of 10.37 falls within the Historic Trend Line -Fairly Valued range.
60.45
EV/EBIT
Xtant Medical Holdings Inc. (XTNT) has a current EV/EBIT of 60.45. The 5-year average EV/EBIT is -7.18. The thresholds are as follows: Strongly Undervalued below -114.71, Undervalued between -114.71 and -60.94, Fairly Valued between 46.58 and -60.94, Overvalued between 46.58 and 100.34, and Strongly Overvalued above 100.34. The current Forward EV/EBIT of 60.45 falls within the Overvalued range.
0.72
PS
Xtant Medical Holdings Inc. (XTNT) has a current PS of 0.72. The 5-year average PS is 1.03. The thresholds are as follows: Strongly Undervalued below -0.37, Undervalued between -0.37 and 0.33, Fairly Valued between 1.73 and 0.33, Overvalued between 1.73 and 2.43, and Strongly Overvalued above 2.43. The current Forward PS of 0.72 falls within the Historic Trend Line -Fairly Valued range.
46.50
P/OCF
Xtant Medical Holdings Inc. (XTNT) has a current P/OCF of 46.50. The 5-year average P/OCF is 34.68. The thresholds are as follows: Strongly Undervalued below -206.64, Undervalued between -206.64 and -85.98, Fairly Valued between 155.35 and -85.98, Overvalued between 155.35 and 276.01, and Strongly Overvalued above 276.01. The current Forward P/OCF of 46.50 falls within the Historic Trend Line -Fairly Valued range.
-836.95
P/FCF
Xtant Medical Holdings Inc. (XTNT) has a current P/FCF of -836.95. The 5-year average P/FCF is -28.01. The thresholds are as follows: Strongly Undervalued below -337.61, Undervalued between -337.61 and -182.81, Fairly Valued between 126.79 and -182.81, Overvalued between 126.79 and 281.60, and Strongly Overvalued above 281.60. The current Forward P/FCF of -836.95 falls within the Strongly Undervalued range.
Xtant Medical Holdings Inc (XTNT) has a current Price-to-Book (P/B) ratio of 1.70. Compared to its 3-year average P/B ratio of 2.23 , the current P/B ratio is approximately -23.92% higher. Relative to its 5-year average P/B ratio of 2.76, the current P/B ratio is about -38.59% higher. Xtant Medical Holdings Inc (XTNT) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -11.94%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -8.23% , the current FCF yield is about -100.00% lower.
1.70
P/B
Median3y
2.23
Median5y
2.76
6.18
FCF Yield
Median3y
-11.94
Median5y
-8.23
Competitors Valuation Multiple
The average P/S ratio for XTNT's competitors is , providing a benchmark for relative valuation. Xtant Medical Holdings Inc Corp (XTNT) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 19.04%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of XTNT increased by 37.77% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 22.69 to 54.59.
The secondary factor is the Revenue Growth, contributed 19.04%to the performance.
Overall, the performance of XTNT in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Xtant Medical Holdings Inc (XTNT) currently overvalued or undervalued?
What is Xtant Medical Holdings Inc (XTNT) fair value?
How does XTNT's valuation metrics compare to the industry average?
What is the current P/B ratio for Xtant Medical Holdings Inc (XTNT) as of Dec 05 2025?
What is the current FCF Yield for Xtant Medical Holdings Inc (XTNT) as of Dec 05 2025?
What is the current Forward P/E ratio for Xtant Medical Holdings Inc (XTNT) as of Dec 05 2025?